Sequana Medical Announces Granting of Key Additional U.S. Patent for DSR

Builds upon existing granted DSR patents in US, Europe, Japan and China Strengthens DSR patent protection based upon extensive clinical and pre-clinical experience Data published in European Journal ...
Science Daily

New treatment option shown for heart failure fluid overload

Clinical researchers found that giving higher doses of the diuretic spironolactone could safely and effectively treat fluid excess in heart failure patients who did not respond to other diuretics.
Nasdaq

CHF Solutions to Host Webinar Discussing Treatment of Fluid Overload in Pediatric Patients

EDEN PRAIRIE, Minn., June 23, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced the company will host an interactive, physician-led webinar to discuss treatment of fluid overload ...
KXAN

AQUAPASS Receives Marketing Approval in Israel, Enabling Access to Novel Therapy for Patients with Fluid Overload

NEWTON, Mass. and SHEFAYIM, Israel, Dec. 8, 2025 /PRNewswire/ -- AQUAPASS, a medical technology company pioneering non-invasive fluid management solutions, has received marketing approval for the ...
Nasdaq

New Case Series Demonstrates Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid Overload

Early findings suggest Aquadex as a potential solution to safely and effectively remove fluid volume for liver disease patients who don’t respond to diuretics MINNEAPOLIS, Feb. 06, 2024 (GLOBE ...
News Medical

Study shows new treatment option for heart failure fluid overload

Higher doses of spironolactone, a diuretic (water pill), can prevent the need for dialysis in selected heart failure patients, a UT Health San Antonio study found. The aggressive approach relieved ...